+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Autoimmune Hemolytic Anemia Drug"

From
Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Autoimmune Hemolyytic Anemia (AIHA) is a condition where the immune system mistakenly attacks and destroys red blood cells, leading to hemolytic anemia. While the core treatment of AIHA typically involves immunosuppressive drugs and corticosteroids, the role of vitamins and dietary supplements is often supportive in nature. Dietary supplements may be used to correct nutritional deficiencies that can occur as a result of AIHA or its treatments. For example, folic acid supplements may be recommended to aid in the production of new red blood cells. Additionally, iron supplements can be important if the patient has iron-deficiency anemia secondary to AIHA. Antioxidant supplements might also be considered, although their efficacy in the context of AIHA specifically is not well-established. The market for supportive treatments in AIHA includes companies focused on providing vitamins and dietary supplements that are often tailored to improve overall hematologic health. These companies may also be involved in creating products aimed at boosting the immune system, though the benefits of such products for AIHA patients must be approached with caution due to the autoimmunity component. Some of the companies participating in this space include NOW Foods, Nature Made, and Garden of Life, which offer a range of vitamin and mineral supplements that may be used by individuals with AIHA to address nutritional gaps in their diets. Show Less Read more